Axel Nordenskjöld

30PUBLICATIONS
37CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous systemPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Dec 17, 2025
Diagnostic Conversion From Psychotic Unipolar Depression to Bipolar and Psychotic Disorders: A Swedish Registry-Based Study.

Ahmed Al-Wandi, Mikael Landén, Axel Nordenskjöld

|Nov 19, 2025
Real-world analysis of pharmacological treatments to prevent relapse after electroconvulsive therapy for major depressive disorder: A nationwide cohort study.

Alexander Kronsell, Axel Nordenskjöld, Robert Bodén

|Oct 03, 2024
Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy.

Robert Sigström, Andreas Göteson, Erik Joas

|May 28, 2024
Electroconvulsive therapy in the maintenance phase of psychotic unipolar depression.

Ahmed Al-Wandi, Mikael Landén, Axel Nordenskjöld

|Apr 11, 2024
Association between electroconvulsive therapy and time to readmission after a manic episode.

Katarzyna Popiolek, Tor Arnison, Susanne Bejerot

|Jan 12, 2024
Unmasking patient diversity: Exploring cognitive and antidepressive effects of electroconvulsive therapy.

Kjersti Sellevåg, Christoffer A Bartz-Johannessen, Ketil J Oedegaard

Pageof 5

Frequent Collaborators

7 joint publications

Mikael Landén

4 joint publications

Ahmed Al-Wandi

4 joint publications

Pouya Movahed Rad

3 joint publications

Charles H Kellner